CBIO Competitors & Alternatives
Compare Crescent Biopharma, Inc. with similar stocks in the same industry
Biotechnology
CBIO
Main Stock$17.15
Tradestie Score
47
Market Cap
$199.71M
Analyst Upside
+78.4%
Top Competitors
241 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARVN
Arvinas, Inc
|
$9.37
|
$670.30M | 37.6 | 41 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$14.34
|
$665.30M | 17.3 | 34 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$17.63
|
$626.91M | - | 57 | Compare |
|
SVRA
Savara Inc.
|
$5.59
|
$611.84M | - | 55 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.28
|
$552.46M | - | 47 | Compare |
|
VSTM
Verastem, Inc.
|
$6.89
|
$541.60M | - | 41 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$14.46
|
$540.97M | - | 48 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$11.87
|
$529.35M | 12.4 | 45 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$107.72
|
$522.78M | - | 47 | Compare |
More CBIO Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
241 stocks in this industry